Mach-1 Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,022
Closed -$702K 176
2025
Q4
$702K Buy
+13,022
New +$626K 0.14% 131
2022
Q4
Sell
-1,860
Closed -$131K 194
2022
Q3
$131K Sell
1,860
-92
-5% -$6.67K 0.14% 57
2022
Q2
$149K Buy
1,952
+242
+14% +$18.4K 0.1% 58
2022
Q1
$124K Sell
1,710
-15
-0.9% -$1.01K 0.08% 36
2021
Q4
$107K Buy
+1,725
New +$101K 0.07% 42
2021
Q3
Sell
-1,710
Closed -$114K 30
2021
Q2
$114K Hold
1,710
0.08% 26
2021
Q1
$107K Buy
1,710
+362
+27% +$22.5K 0.09% 28
2020
Q4
$83K Buy
+1,348
New +$82.9K 0.09% 63

Other funds holding BMY

Mach-1 Financial Group's BMY Position: Q1 2026 in Review

Mach-1 Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 13,022 shares — an estimated $702K sold.

Mach-1 Financial Group first reported a position in BMY in Q4 2020 and held it in 8 quarters. The position peaked at $702K in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mach-1 Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Mach-1 Financial Group sold 13,022 Bristol-Myers Squibb shares in Q1 2026, an estimated $702K.
  • Mach-1 Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 8 quarters.
  • Mach-1 Financial Group's Bristol-Myers Squibb position peaked at $702K in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.